Cell therapy can be considered as a group of new techniques, or technologies, that work by replacing diseased or dysfunctional cells with healthy, functioning ones.

These techniques are being applied to a wide range of human diseases, including many types of cancer, neurological diseases such as Parkinson's and Lou Gehrig's disease, spinal cord injuries, and heart disease. Even though cells are indispensable in performing many important functions for the body, they can also exist outside the body. They can live and divide into "cultures," special solutions in test tubes or Petrie dishes. This ability to isolate certain cell types from other cells under controlled conditions has allowed scientists to study them independently of the organ or system they are normally a part of.

Through the isolation and targeted manipulation of cells, scientists are researching ways to identify young, regenerating ones that can be used to replace damaged or dead ones in diseased organs. This therapy is similar to the process of organ transplant, but in this case, it's the transplantation of cells rather than organs.

Stem cells, also known as progenitor cells, are primitive cells that give rise to other types of cells. There are several kinds of stem cells. Totipotent cells are considered the "master" cells of the body because they contain all the genetic information needed to create all the cells of the body plus the placenta, which nourishes the human embryo.

Human cells have this capacity only during the first few divisions of a fertilized egg. After three to four divisions of totipotent cells, there follows a series of stages in which the cells become increasingly specialized. The next stage of division results in pluripotent cells, which are highly versatile and can give rise to any cell types except the cells of the placenta.

At the next stage, cells become multipotent, this mean that they can give rise to several other cell types, but those types are limited in number. An example of multipotent cells is hematopoietic cells-blood stem cells that can develop into several types of blood cells, but cannot develop into brain cells. At the end of the long chain of cell divisions that make up the embryo are "terminally differentiated" cells; cells that are considered to be permanently committed to a specific function.

An embryonic stem cell originates from a group of cells called the inner cell mass, which is part of the early (four to five day-old) embryo called the blastocyst. Once removed from the blastocyst, the cells of the inner cell mass can be cultured into embryonic stem cells.

These embryonic stem cells are not themselves embryos. In fact, evidence is suggesting that these cells do not behave in the laboratory as they would in the developing embryo. The conditions in which these cells develop in culture are likely to differ from those in the developing embryo.

Adult (Repair) and embryonic stem cells differ in the way they operate and what they become. It is rumored (by millions of dollars worth of false hype that embryonic stem cells (ESC) can become all cell types of the body because they are pluripotent. Maybe,maybe not, but one thing is sure, NO SCIENTIFIC PAPER HAS EVER BEEN PUBLISHED THAT PROVES THIS.

Repair Stem Cells RSC OR ASC) are generally limited to differentiating into different cell types of their tissue of origin. ANOTHER INTENTIONAL LIE BY BIG MEDICINE. Not only has no paper ever been published to prove this lie, there are HUNDREDS of published papers that disprove it! Every month, it seems, a new RSC is uncovered and it can become a specific type of raw tissue and also other types of tissue.

The greatest difference between them, though is in howe they act. RSC, when placed in a weakened or partially destroyed body organ, STAY THERE and multiply so they can do the huge repair job they have taken on. ESC can improve an organ for a day or more, but then THEY WANDER OFF because they want to do what they were created to do: BECOME A BABY. Since they are not in a friendly-to-baby environment, they panic and try anyway. The result is never good. Often it is cancer.

RSC are being used in over 1500 clinical trials worldwide, almost every one of them completed successfully or on their way to success. In addition, commercial treatments have treated over 30,000 patients for over 100 chronic diseases, with over 20,000 successes.

ESC have shown great success in the laboratory, treating mice for everything imaginable. Unfortunately, this NEVER seems to translate in human treatments. Indeed there is but one completed ESC clinical trial for spinal cord patients which failed miserably and was stopped, along with many different false reasons given. They are still hiding the truth about cancerous effects. Another clinical trial has the support of every lab and all of academia which gets tens of millions from Pharma to promote that which never has worked, does not now, and never will, for the current 100+ RSC treatments. That should tell you all you need to know about "standard medicine" in North America: Profitable to Big Business and all the institutions grabbing for those hundreds of millions, but never a thought of the 50 million+ chronic disease sufferers whose only purpose is to provide thos profits.

Medical procedures include some risks and side-effects, including risks relating to the anesthetic, infections, complications when the wound is healing, and temporary post-surgical pain. Bleeding can occur on rare occasions. The RSCI approved facilities ELIMINATE surgical risks by using state-of-the-art medical equipment, especially catheters, and ensuring strict adherence to hygiene guidelines.